Endovia Health Sciences amends agreement
- Entered into letter agreement with C/M Capital Master Fund, LP on 2026-10-15
- Increased beneficial ownership limit from 4.99% to 9.99%
- Waived notice requirements in Purchase Agreement
Every EDGAR filing for Endovia Health Sciences, Inc. (EDVA), newest first, with AI summaries and stories.
Next: 10-Q expected ~Nov 17 (deadline Nov 16)
Michael Breen Bondurant, new insider at SBEVW
Michael Breen Bondurant, reporting
Michael Breen Bondurant, insider filing for SBEVW
Michael Breen Bondurant, reporting
Thomas Butler Fore, insider filing for SBEVW
Thomas Butler Fore, reporting